COIMBATORE: Under the National Health Mission (NHM), a group of surgical oncologists from eight medical college hospitals ...

Newswatch 16's Justin Gick spoke with a doctor about gynecological cancer and how early detection and access to care can save ...

Over the past four decades, death rates for most cancers have declined. Uterine cancer is an exception. Now the fourth most ...

Gynaecological cancers, ranging from ovarian to cervical and uterine types, often develop slowly. While some causes are ...

GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.

A team of 30 doctors helped Suze Lopez, 41, deliver her son — and remove the tumor — in a "profound" medical marvel.

Women should be vigilant about subtle bodily changes that could signal cancer. Persistent bloating, unusual vaginal bleeding, ...

Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

Weight-loss drugs have “little or no effect” on reducing the risk of cancers related to obesity, according to a new study.

Although numerous early signs and symptoms of cancer may be benign or ordinary, a substantial number are not. Recognizing ...

In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the ...